AT406 for neoadjuvant treatment of epithelial ovarian cancer [ID1428]
Discontinued
Reference number: GID-TA10809
Following on from information provided to NICE by the company in February 2021, the appraisal of AT406 for neoadjuvant treatment of epithelial ovarian cancer [ID1428] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.